---
title: "000705.SZ (000705.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/000705.SZ/news.md"
symbol: "000705.SZ"
name: "000705.SZ"
parent: "https://longbridge.com/zh-CN/quote/000705.SZ.md"
datetime: "2026-03-10T23:45:24.997Z"
locales:
  - [en](https://longbridge.com/en/quote/000705.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000705.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000705.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/000705.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000705.SZ/news.md)


# 000705.SZ (000705.SZ) — 相关新闻

### [ZHEJIANG ZHENYUAN terminates the issuance of stocks to specific objects and withdraws the application documents](https://longbridge.com/zh-CN/news/262024929.md)
*2025-10-21T10:07:08.000Z*
> According to the Zhitong Finance APP, Zhejiang Zhenyuan announced that since the company disclosed the issuance of share

### [ZHEJIANG ZHENYUAN: The S1 production line is scheduled to officially start production at the end of August](https://longbridge.com/zh-CN/news/254749599.md)
*2025-08-27T07:26:31.000Z*
> On August 27th, ZHEJIANG ZHENYUAN stated on the interactive platform that the S1 production line of Zhenyuan Biotechnolo

### [ZHEJIANG ZHENYUAN: The net profit for the mid-term report in 2025 is 56.2637 million yuan](https://longbridge.com/zh-CN/news/254239735.md)
*2025-08-22T22:21:22.000Z*
> ZHEJIANG ZHENYUAN released its interim report on August 23, 2025, with total operating revenue of 1.283 billion yuan and

### [ZHEJIANG ZHENYUAN: The synthetic biology project of Zhenyuan Bio is expected to be put into production in the third quarter](https://longbridge.com/zh-CN/news/250682917.md)
*2025-07-30T01:07:12.000Z*
> ZHEJIANG ZHENYUAN stated on the interactive platform that the synthetic biology project of Zhenyuan Biotech is expected 

### [](https://longbridge.com/zh-CN/news/249057770.md)
*2025-07-18T01:28:55.000Z*
> The A-share pharmaceutical commercial sector is actively bidding, with ZHEJIANG ZHENYUAN and HRPC both hitting the daily

### [The synthetic biology concept strengthens, ALK hits the limit up](https://longbridge.com/zh-CN/news/248883678.md)
*2025-07-17T02:20:31.000Z*
> The synthetic biology concept is gaining strength. As of 10:16 AM, ZHEJIANG ZHENYUAN and ALK have reached the daily limi

### [Benefiting from the intensive release of policy dividends, the innovative drug industry has entered the fast lane of development](https://longbridge.com/zh-CN/news/248833516.md)
*2025-07-16T15:53:30.000Z*
> Recently, the biopharmaceutical sector has been active, with the innovative drug industry benefiting from policy dividen

### [Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limit](https://longbridge.com/zh-CN/news/248724388.md)
*2025-07-16T06:11:02.000Z*
> In the afternoon, the pharmaceutical stocks continued to rise, with both innovative drugs and generic drugs performing w

### [](https://longbridge.com/zh-CN/news/248695129.md)
*2025-07-16T01:10:08.000Z*
> ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in 

### [The pharmaceutical commercial sector has seen a short-term decline, with NO.1 PHARMACY dropping over 6%](https://longbridge.com/zh-CN/news/242101917.md)
*2025-05-28T01:35:11.000Z*
> The pharmaceutical commercial sector has declined in the short term, with NO.1 PHARMACY dropping over 6%, and YIXINTANG,